Balance Sheet

v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Current assets    
Cash $ 1,790,391 $ 661,415
Accounts receivable, net 801,442 606,885
Inventory, net 1,636,419 1,431,556
Due from VitaMedica transition 171,218 212,358
Prepaid expenses and other receivables 390,810 502,188
Assets available for sale - Building 0 4,005,516
Purchase price receivable - VitaMedica 2,000,000 2,000,000
Purchase price receivable - E-core 0 2,000,000
Total current assets 6,790,280 11,419,918
Property and equipment, net 2,338,199 2,356,556
Intangible assets, net 220,681 239,871
Goodwill 848,854 848,854
Deferred tax asset 5,948,858 5,948,858
Other assets 206,360 278,435
Right-of-use asset, net 2,249,796 2,418,596
Total other assets 11,812,748 12,091,170
Total assets 18,603,028 23,511,088
Current liabilities    
Accounts payable 575,238 481,647
Accrued compensation 952,601 1,098,856
Deferred revenue 178,016 235,255
Accrued liabilities 317,239 736,407
Accrued interest 453,280 476,018
Acquisition payable 413,152 413,152
Related party advances, net 0 100,000
Current portion of note payable 140,000 0
Current portion of convertible notes payable 387,500 0
Current portion of related party note payable 125,000 0
Current portion of Cygnet subsidiary notes payable 5,447,565 5,447,565
Note payable on building for sale 0 2,634,538
Current portion of operating lease payable 781,810 1,031,714
Total current liabilities 9,771,401 12,655,152
Operating lease payable, net of current portion 1,842,505 1,732,606
Related party note payable 375,000 500,000
Note payable 420,000 557,429
Convertible notes payable 1,162,500 1,550,000
Total long-term liabilities 3,800,005 4,340,035
Stockholders' equity    
Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 25,000 and 25,000 shares issued and outstanding, respectively 25 25
Common stock, $0.001 par value, 100,000,000 shares authorized, and 1,045,429 and 1,045,429 shares issued and outstanding, respectively 1,045 1,045
Additional paid in capital 53,515,742 53,374,444
Accumulated deficit (48,485,190) (46,859,613)
Total stockholders' equity 5,031,622 6,515,901
Total liabilities and stockholders' equity $ 18,603,028 $ 23,511,088

Source